Susquehanna International Group, LLP Ptc Therapeutics, Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 106,067 shares of PTCT stock, worth $5.29 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
106,067
Previous 101,669
4.33%
Holding current value
$5.29 Million
Previous $4.59 Million
17.78%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding PTCT
# of Institutions
284Shares Held
78.5MCall Options Held
223KPut Options Held
156K-
Vanguard Group Inc Valley Forge, PA8.61MShares$429 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$387 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$373 Million6.25% of portfolio
-
Armistice Capital, LLC New York, NY5.43MShares$271 Million4.22% of portfolio
-
Wellington Management Group LLP Boston, MA5.42MShares$270 Million0.05% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.57B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...